Hemosiderosis medical therapy: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 7: Line 7:


==Medical Therapy==
==Medical Therapy==
*There is no gold standrad [[treatment]] for [[IPH]]; the mainstay of therapy is supportive care based on the [[presentation]] and [[acute]] vs. [[chronic]] nature of the patient.
*There is no gold standard [[treatment]] for [[IPH]]; However high dose steroids are frequently used to control symptoms, with good results.<ref name="pmid32491447">{{cite journal |vauthors=Madu A, Siddiqui AH |title= |journal= |volume= |issue= |pages= |date= |pmid=32491447 |doi= |url=}}</ref>
The mainstay of therapy is supportive care based on the [[presentation]] and [[acute]] vs. [[chronic]] nature of the patient.
*[[Blood transfusion]] should be done to correct severe [[anemia]] and shock during the [[acute]] phase.
*[[Blood transfusion]] should be done to correct severe [[anemia]] and shock during the [[acute]] phase.
*Patients with [[acute]] [[IPH]] and [[respiratory failure]] [[secondary]] to [[alveolar]] [[hemorrhage]] may require invasive [[ventilation]] support.  
*Patients with [[acute]] [[IPH]] and [[respiratory failure]] [[secondary]] to [[alveolar]] [[hemorrhage]] may require invasive [[ventilation]] support.  

Latest revision as of 08:34, 28 September 2020

Hemosiderosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemosiderosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemosiderosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemosiderosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemosiderosis medical therapy

CDC on Hemosiderosis medical therapy

Hemosiderosis medical therapy in the news

Blogs on Hemosiderosis medical therapy

Directions to Hospitals Treating Hemosiderosis

Risk calculators and risk factors for Hemosiderosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There is no treatment for IPH; the mainstay of therapy is supportive care based on the presentation and acute vs. chronic nature of the patient. Immuno-suppressants in combination with steroids is used for severe cases. Supportive therapy for IPH includes blood transfusion to correct severe anemia, and invasive ventilation support for respiratory failure secondary to alveolar hemorrhage.

Medical Therapy

  • There is no gold standard treatment for IPH; However high dose steroids are frequently used to control symptoms, with good results.[1]

The mainstay of therapy is supportive care based on the presentation and acute vs. chronic nature of the patient.

References

  1. Madu A, Siddiqui AH. PMID 32491447 Check |pmid= value (help). Missing or empty |title= (help)

Template:WH Template:WS